Report Details:
15 Companies Covered
111 Pages
Market Highlights
Light Therapy Market size was valued at USD 1.10 Billion in 2025, and the market is projected to grow from USD 1.15 Billion in 2026 to USD 1.74 Billion by 2035, registering a CAGR of 4.72% during the forecast period 2026–2035.
MRFR recognizes the following companies as the key players in the Global Light Therapy Market — Beurer (Germany), Northern Light Technology (Canada), BioPhotas (US), Koninklijke Philips (Netherlands), Lumie (UK), Chal-Tec GmbH (Germany), Lucimed SA (Belgium), Verilux (US), Nature Bright (Taiwan), and Zepter International (Switzerland).
The market growth is primarily driven by the increasing prevalence of psychological and dermatological conditions such as Seasonal Affective Disorder (SAD), depression, eczema, and psoriasis, along with a growing preference for non-invasive and home-based treatment options. Light therapy uses controlled exposure to specific wavelengths—such as blue, red, and white light—to correct biological rhythms and treat various medical and cosmetic conditions.
The rise in awareness of mental health and the increasing number of individuals suffering from sleep disorders have significantly fueled the adoption of light therapy devices. According to the World Health Organization, depression affects more than 264 million people globally, and approximately 52 million adults in the U.S. suffer from mental illnesses. Light therapy offers a safe, cost-effective, and drug-free treatment alternative for these disorders.
In addition, technological advancements such as portable LED-based devices and customizable light therapy products have increased accessibility and treatment precision. Companies such as Beurer and Philips are introducing innovative products like Luminia Pro and ReviveLED Pro, enabling more personalized treatment experiences.
Moreover, supportive government initiatives, mental health campaigns, and clinical validations (such as the Symbyx Neuro study on Parkinson’s disease patients) have strengthened the clinical acceptance of light therapy. The combination of these factors is projected to significantly drive global market expansion over the next decade.
Segment Analysis
The Global Light Therapy Market has been segmented based on Product Type, Application, Light Type, and End User.
By Product Type:The market is segmented into Light Box, Floor and Desk Lamps, Light Visor, HDST, and Others.The Light Box segment dominated the market in 2024, attributed to its widespread use for treating Seasonal Affective Disorder (SAD). Additionally, dawn simulators are gaining traction as they help regulate circadian rhythms and are more user-friendly for home use.
By Application:The market is segmented into Psoriasis, Vitiligo, Eczema, Acne Vulgaris, and Others.The Psoriasis segment held the largest market share in 2024 and is expected to maintain its dominance due to the rising incidence of chronic skin conditions globally. Approximately 25–30% of psoriasis patients experience severe symptoms, increasing the demand for effective therapies like light therapy.
By Light Type:The market is segmented into Blue Light, Red Light, White Light, and Others.The Blue Light segment dominated in 2024 due to its efficacy in treating skin cancer and sun damage. Meanwhile, White Light is used widely to manage SAD and depression, and Red Light Therapy is expected to exhibit the fastest growth owing to its benefits in arthritis and joint pain management.
By End User:The market is segmented into Homecare Settings, Dermatology Clinics, and Others.The Dermatology Clinics segment held the largest share in 2024, driven by increasing cases of psoriasis, eczema, and acne. However, the Homecare Settings segment is anticipated to grow rapidly during the forecast period due to the availability of cost-effective, easy-to-use devices for home use.
Region Analysis
By Region, the Light Therapy Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.
North America accounted for the largest market share in 2024 and is expected to retain its dominance throughout the forecast period. The region’s growth is fueled by the rising incidence of mental health disorders, sleep disturbances, and skin conditions. According to the American Sleep Association, nearly 70 million U.S. adults suffer from sleep disorders. The strong presence of leading manufacturers such as Philips and Beurer further supports market expansion in this region.
Europe held the second-largest market share in 2024. Market growth is driven by the increasing prevalence of seasonal affective disorder and dermatological conditions, as well as the growing popularity of aesthetic treatments. The UK is the fastest-growing market in the region, while Germany holds the largest market share.
Asia-Pacific is projected to register the fastest CAGR of 5.55% during the forecast period. The region’s growth is driven by rising cases of skin disorders, pre-term births, and growing awareness of light-based therapies. Countries such as India, China, and Japan are key growth engines due to expanding healthcare infrastructure and high adoption of portable phototherapy devices.
The Rest of the World region, including Latin America and the Middle East, is witnessing steady growth driven by increasing healthcare awareness and availability of cost-effective devices.
Key Findings of the Study
- Light Boxes led the Light Therapy Market in 2025, capturing a 29.1% revenue share, driven by widespread adoption for mood disorder management and clinical dermatology applications.
- Hand-held Devices are poised to expand at a 5.20% CAGR through 2035 as portable, app-connected units gain traction among home-care users seeking targeted treatment convenience.
- North America commanded the dominant regional position in the Light Therapy Market with a 47.4% revenue share in 2025.
- Asia-Pacific represents the fastest-growing region at a 5.39% CAGR through 2035.
